150 related articles for article (PubMed ID: 20042796)
1. Quantification of residual dimethylsulfoxide after washing cryopreserved stem cells and thawing tissue grafts.
Decot V; Houzé P; Stoltz JF; Bensoussan D
Biomed Mater Eng; 2009; 19(4-5):293-300. PubMed ID: 20042796
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing.
Calmels B; Houzé P; Hengesse JC; Ducrot T; Malenfant C; Chabannon C
Bone Marrow Transplant; 2003 May; 31(9):823-8. PubMed ID: 12732892
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing.
Rodríguez L; Velasco B; García J; Martín-Henao GA
Transfusion; 2005 Aug; 45(8):1391-7. PubMed ID: 16078930
[TBL] [Abstract][Full Text] [Related]
4. Adoption of long-term cultures to evaluate the cryoprotective potential of trehalose for freezing hematopoietic stem cells.
Scheinkönig C; Kappicht S; Kolb HJ; Schleuning M
Bone Marrow Transplant; 2004 Sep; 34(6):531-6. PubMed ID: 15286692
[TBL] [Abstract][Full Text] [Related]
5. Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators.
Akkök CA; Liseth K; Hervig T; Ryningen A; Bruserud Ø; Ersvaer E
Cytotherapy; 2009; 11(6):749-60. PubMed ID: 19878061
[TBL] [Abstract][Full Text] [Related]
6. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
[TBL] [Abstract][Full Text] [Related]
7. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients -- impact of cryopreservation with dimethylsulfoxide.
Horacek JM; Jebavy L; Jakl M; Zak P; Mericka P; Maly J
Exp Oncol; 2009 Jun; 31(2):121-2. PubMed ID: 19550404
[TBL] [Abstract][Full Text] [Related]
9. Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres.
Windrum P; Morris TC; Drake MB; Niederwieser D; Ruutu T;
Bone Marrow Transplant; 2005 Oct; 36(7):601-3. PubMed ID: 16044141
[TBL] [Abstract][Full Text] [Related]
10. A simplified technique for the cryopreservation of vein allografts.
Ruddle AC; George SJ; Armitage WJ; Alexander EL; Mitchell DC
Eur J Vasc Endovasc Surg; 2000 Mar; 19(3):233-7. PubMed ID: 10753685
[TBL] [Abstract][Full Text] [Related]
11. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors.
Almici C; Ferremi P; Lanfranchi A; Ferrari E; Verardi R; Marini M; Rossi G
Haematologica; 2003 Dec; 88(12):1390-5. PubMed ID: 14687993
[TBL] [Abstract][Full Text] [Related]
12. Determination of residual dimethylsulfoxide in cryopreserved cardiovascular allografts.
Díaz Rodríguez R; Van Hoeck B; De Gelas S; Blancke F; Ngakam R; Bogaerts K; Jashari R
Cell Tissue Bank; 2017 Jun; 18(2):263-270. PubMed ID: 28058524
[TBL] [Abstract][Full Text] [Related]
13. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity.
Syme R; Bewick M; Stewart D; Porter K; Chadderton T; Glück S
Biol Blood Marrow Transplant; 2004 Feb; 10(2):135-41. PubMed ID: 14750079
[TBL] [Abstract][Full Text] [Related]
14. Protocols for thawing and cryoprotectant dilution of heart valves.
Armitage WJ; Dale W; Alexander EA
Cryobiology; 2005 Feb; 50(1):17-20. PubMed ID: 15710365
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cord blood thawing methods on cell recovery, potency, and infusion.
Regan DM; Wofford JD; Wall DA
Transfusion; 2010 Dec; 50(12):2670-5. PubMed ID: 21126251
[TBL] [Abstract][Full Text] [Related]
16. The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells.
Katayama Y; Yano T; Bessho A; Deguchi S; Sunami K; Mahmut N; Shinagawa K; Omoto E; Makino S; Miyamoto T; Mizuno S; Fukuda T; Eto T; Fujisaki T; Ohno Y; Inaba S; Niho Y; Harada M
Bone Marrow Transplant; 1997 Feb; 19(3):283-7. PubMed ID: 9028559
[TBL] [Abstract][Full Text] [Related]
17. Automatic washing of thawed haematopoietic progenitor cell grafts: a preclinical evaluation.
Abonnenc M; Pesse B; Tissot JD; Barelli S; Lion N
Vox Sang; 2017 May; 112(4):367-378. PubMed ID: 28337763
[TBL] [Abstract][Full Text] [Related]
18. Improved postthaw viability and in vitro functionality of peripheral blood hematopoietic progenitor cells after cryopreservation with a theoretically optimized freezing curve.
Tijssen MR; Woelders H; de Vries-van Rossen A; van der Schoot CE; Voermans C; Lagerberg JW
Transfusion; 2008 May; 48(5):893-901. PubMed ID: 18298597
[TBL] [Abstract][Full Text] [Related]
19. Simplified method for cryopreservation of islets using hydroxyethyl starch and dimethyl sulfoxide as cryoprotectants.
Maruyama M; Kenmochi T; Sakamoto K; Arita S; Iwashita C; Kashiwabara H
Transplant Proc; 2004 May; 36(4):1133-4. PubMed ID: 15194395
[TBL] [Abstract][Full Text] [Related]
20. Islet cryopreservation using intracellular preservation solutions.
Lakey JR; Rajotte RV; Fedorow CA; Taylor MJ
Cell Transplant; 2001; 10(7):583-9. PubMed ID: 11714192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
